LAUREN UPTON: Open Payments
NPI 1043659493 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 42 payments from 7 companies in 2025. Trend: 2023 $3,414 · 2024 $2,000 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $401 |
| Regeneron Healthcare Solutions, Inc. | 10 | $345 |
| AERIN MEDICAL INC. | 5 | $149 |
| Optinose US, Inc. | 4 | $110 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
Products named: DUPIXENT, VIVAER STYLUS, Xhance, NUCALA, TEZSPIRE, TRELEGY ELLIPTA, NEFFY.
Industry payments across TX — which companies pay providers there.
